117
Participants
Start Date
August 31, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
October 31, 2015
Anlotinib
Anlotinib QD po.
Placebo capsule
Placebo QD po.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
Beijing chest hospital，capital medical university, Beijing
Jilin province tumor hospital, Changchun
Chest hospital affiliated to Shanghai jiaotong university, Shanghai
Shanghai Changhai Hospital, Shanghai
The First Affiliated Hospital of Suzhou University, Suzhou
Shandong Province Tumor Hospital, Jinan
Tianjin Medical University Cancer Hospital, Tianjin
Zhejiang Cancer Hospital, Hangzhou
Xinqiao Hospital, Third Military Medical University, Chongqing
Hunan Province Tumor Hospital, Changsha
West China Hospital,Sichuan University, Chengdu
The first affiliated hospital,zhejiang university, Hangzhou
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY